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phobic interaction chromatography; EM, electron micrGlutamine synthetase enzymes (GSs) are large oligomeric enzymes that play a critical role in nitrogen
metabolism in all forms of life. To date, no crystal structures exist for the family of large (1 MDa) type
III GS enzymes, which only share 9% sequence identity with the well characterized GSI and GSII enzymes.
Here we present a novel protocol for the isolation of untagged Bacteroides fragilis GlnN expressed in an
auxotrophic Escherichia coli strain. The rapid and scalable two-step protocol utilized differential precip-
itation by divalent cations followed by affinity chromatography to produce suitable quantities of homog-
enous material for structural characterization. Subsequent optimizations to the sample stability and
solubility led to the discovery of conditions for the production of the first diffraction quality crystals of
a type III GS enzyme.
 2010 Elsevier Inc. All rights reserved.Introduction
Glutamine synthetases (GSs)1 are large oligomeric enzymes that
play a central role in nitrogen assimilation, catalysing the condensa-
tion of ammonium and glutamate to form glutamine, a precursor for
the synthesis of many critical bio-molecules. The ancient [1] and
ubiquitous [2] GS superfamily is, therefore, evolutionarily diverse
and can be divided into three main groupings, namely GSI, GSII
and GSIII, on the basis of amino-acid divergence [3].
GSI and GSII enzymes have been purified from numerous bacte-
rial and eukaryotic sources, respectively, over the past five decades
of biochemical and structural investigations into their functioning
and regulation [4]. The first crystal structure of a GSI enzyme [5]
was solved using material prepared from an adenylylation defi-
cient Salmonella typhimurium strain using a combination of simple
differential precipitation techniques and nucleotide-analogue
affinity chromatography [6]. Since then, advances in recombinant
DNA technology and the advent of affinity purification technolo-
gies have greatly facilitated the isolation of GS material suitable
for crystallization. The first crystal structure of a GSII enzymell rights reserved.
ope Unit, University of Cape
. Fax: +27 021 689 1528.
ooyen).
E, cell-free extract; AGB, Affi-
-glutamyl transferase; ANX,
chromatography; HIC, hydro-
oscopy.was of the Zea mays GS1a protein [7], which was heterologously
expressed in Escherichia coli and purified using a combination of
anion exchange and affinity chromatography steps [8]. More re-
cently, several structures of GSII enzymes purified with affinity
tags [9,10] have been reported.
In comparison, GSIII enzymes have only been isolated and char-
acterized from a small number of sources [11–13] despite the
widespread occurrence of homologues in a number of evolution-
arily divergent organisms [14–16], including, the anaerobic patho-
genic protozoan Trichomonas vaginalis [17]. To date, the only
structural information describing the large GSIII enzymes
(1 MDa), which share only 9% sequence identity with the GSI
enzymes, is from a low-resolution cryo-EM reconstruction of the
GlnN enzyme from the opportunistic human pathogen Bacteroides
fragilis [3]. A detailed understanding of the functioning and evolu-
tion of these divergent enzymes in light of the known structure–
function relationships of the other GS families is, therefore, still
lacking. Although the current purification protocols [3,11] are suf-
ficient for the preparation of small quantities of material for
microscopy and biochemical studies, the poor yields, resulting
from protein solubility and stability issues, represent a barrier to
the attainment of suitable material for crystallization and the
achievement of these goals.
Here we present a novel scheme for the rapid isolation of suit-
able quantities of pure GlnN protein and the subsequent sample
optimizations that have lead to the first diffraction quality crystals
of a GSIII enzyme.
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All reagents and chemicals were sourced from Sigma–Aldrich
unless otherwise stated.Expression and cell lysis
The glutamine synthetase from B. fragilis BF-1, GlnN, was ex-
pressed constitutively from a pEcoR1-derived low copy number
plasmid, pJS139, in an auxotrophic E. coli strain, YMC11 (glnA,
ntrB, ntrC, ApS) [18] as described previously [3] but without
the low-nitrogen induction and CTAB steps. Following 16 h growth
in Luria broth [19] containing ampicillin (100 lg/ml) at 37 C with
aeration, cells were collected by centrifugation for 15 min at
7500 rpm at 4 C and resuspended in 1/50th of the original culture
volume of extraction buffer (50 mM imidazole, 50 mM KCl, pH 7.1).
Cells were then disrupted by sonication for 4 min on ice using a
Misonix sonicator fitted with a microtip operating at a power out-
put of 9 W and cell-free extract (CFE) was then prepared by centri-
fugation at 15,000 rpm for 30 min at 4 C. For long-term storage,
CFE was diluted 1:2 with glycerol, aliquoted into Sterilin plastic
tubes, flash-frozen in liquid nitrogen, and then placed at 80 C.Protein purification
Frozen CFE was thawed and diluted 1:2 with extraction buffer
(50 mM imidazole, 50 mM KCl, pH 7.1). ZnCl2 was then added to
a final concentration of 2 mM and the preparation was left to pre-
cipitate for 1 h at room temperature. Precipitated material was col-
lected by centrifugation at 15,000 rpm at 4 C for 30 min and
resuspended, using a Dounce homogenizer, in ice-cold wash buffer
(15 mM imidazole, 2 mM MgCl2, pH 7.1). Following recollection of
the washed material, a solubilization step was performed in resus-
pension buffer (50 mM imidazole, 500 mM KCl, 10% glycerol, pH
7.1). Insoluble material remaining after 1 h at 4 C was removed
by a 30-min centrifugation step at 14,000 rpm in a desktop centri-
fuge at 4 C. Before loading onto the pre-equilibrated 5 ml Affi-Gel
Blue (AGB) HiTrap affinity column (GE Healthcare), the superna-
tant was diluted 1:10 with ice-cold AGB equilibration buffer
(50 mM imidazole, pH 7.1, 50 mM KCl, 20 mM MgCl2, 10% glycerol,
and 0.02% sodium azide) and filtered through a 0.45-lm filter. The
column was then washed with 5 volumes of equilibration buffer
before elution of the bound protein with 2 volumes of equilibration
buffer containing 10 mM ATP. A period of 5 min was allowed to
elapse between the application of the first and second volumes
of elution buffer. All chromatography steps were carried out at a
flow rate of 1 ml/min at ambient temperature.
After chromatographic purification, methionine sulphoximine
(MetSox) was added to the eluted fraction at a final concentration
of 8 mM and the sample was stored for 16 h at 4 C. This final prep-
aration was concentrated to 6 mg/ml using Microsep and Nanosep
10 kDa MWCO centrifugal concentrators (Pall Corporation). The fi-
nal preparation was divided into 10 ll aliquots and flash-frozen in
NUNC™ CryoTubes™ (Thermo Fisher) for storage under liquid
nitrogen.Biochemical assays and protein identification
Protein concentrations were estimated using the Bradford assay
[20] with Bio-Rad reagents and bovine serum albumin standards.
Results of assays prepared in 96 well NUNC™ plates were read
using a Titertek Multiscan plus MKII plate reader fitted with a
595-nm filter and data processing was carried out with Genesis
Lite.GS activity was assayed by the c-glutamyl transferase (GGT) as-
say as described by Bender et al. [21] and subsequently modified
by Southern et al. [11]. Total assay volumes including reaction mix-
tures and samples were also reduced from 1.5 ml to 250 ll to allow
measurement in the Titertek Multiscan plate reader. Specific activ-
ity was expressed as lmoles of glutamyl hydroxamate formed per
min, per mg protein, and 1 lmol of glutamyl hydroxamate gave
2.916 absorbance units at a wavelength of 540 nm.
Discontinuous SDS–PAGE was carried out according to Laemmli
[22] using a Mini-PROTEAN 3 cell from Bio-Rad. Acrylamide (19:1
monomer:cross-linker) was used to prepare 5% stacking gels and
7.5 or 10% separating gels. Pre-stained molecular weight markers
(Fermentas Life Sciences) were included in all electrophoretic sep-
arations. Gels were stained either with 0.25% Coomassie Brilliant
Blue R250 in 45% methanol and 10% acetic acid or by a non-ammo-
niacal silver-staining protocol [23] using reagents from the GE
Healthcare PlusOne™ Silver-Staining Kit. Protein purity was esti-
mated by densitometry using the program IMAGEJ [24]. Peak areas,
corresponding to bands in the lane under investigation, were cal-
culated after baseline subtraction, and the purity of the GlnN band
was determined from the ratio of its peak area to the total for all
the bands in the lane.Crystallization and preliminary diffraction characterization
GlnN, stored under liquid nitrogen, was thawed, diluted to
2 mg/ml with AGB equilibration buffer, and clarified by centrifu-
gation at 14,000 rpm in desktop centrifuge prior to the setting
up of modified microbatch crystallization conditions [25]. Equal
volumes (1 ll each) of protein and precipitant (reagent 20 from
Hampton Research Crystal Screen diluted 1:2 with distilled
H2O) were dispensed under 5 ml Al’s oil (Hampton Research) in
72 well microbatch plates (Greiner) and stored at ambient tem-
perature (21–23 C). All assessments of crystal growth and
manipulations were performed on a Leica MZ6 stereo microscope
fitted with a CLS 150X cold light source. Photographs of crystals
were captured with a Zeiss Axiocam attached to a Nikon Diaphot
inverted microscope fitted with a 20 short working distance
objective lens.
The identity of the proteins comprising the crystals was con-
firmed using silver-stained SDS–PAGE. Crystals were washed seri-
ally in four droplets (2 ll) of crystallization solution (Hampton
condition 20 diluted 1:2 with H2O) placed under oil in the micro-
batch plate and finally dissolved in a drop of diluted SDS–PAGE
loading buffer (1:2 H2O) before electrophoretic analysis.
Diffraction analyses were carried out on BM14 at the ESRF (Gre-
noble). Crystals were looped using LithoLoops™ fitted in Hampton
HT Crystal Caps and cryo-protected with Paratone-N oil (Hampton
Research) prior to being flash-cooled in liquid nitrogen. Data (1
oscillations) were collected at 100 K using 0.95373 Å wavelength
X-rays (200 mA beam current) with an exposure of 120 s and a
crystal-to-detector distance of 324.8 mm.Electron microscopy of GlnN crystals
Several microlitres of crystallization solution were removed and
applied to EM grids coated with a glow-discharged thin carbon
support film, before being stained with 2% uranyl acetate solution
using the droplet method [26]. Electron micrographs were re-
corded by a Proscan 2048  2048 slow-scan CCD camera, with
14 lm pixels, using a Leo 912 TEM operating at 120 kV with
zero-loss energy filtering. Fourier transforms were calculated using
a FFT plug-in [27] in Paint Shop Pro and patch correlation aver-
ages were calculated in 2DX after Fourier filtering [28].
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Two major limitations characterized the previously reported
isolations of GlnN from the heterologous YMC11 E. coli (pJS139)
expression system, namely, limited solubility and the co-purifica-
tion of large molecular weight contaminating complexes. Several
alternate purification technologies and strategies were, therefore,
evaluated for their ability to address these issues. These techniques
included differential PEG precipitations, ANX Sepharose anion-ex-
change chromatography (ANX), HR Sephacryl size-exclusion
chromatography (SEC), nucleotide-analogue dye affinity chroma-
tography (AF) matrices including Affi-Gel Blue (AGB) and Reactive
Red Sepharose, and Butyl Sepharose hydrophobic interaction chro-
matography (HIC) (data not shown). The final purification scheme
presented below is a result of these optimizations, which paral-
leled the screening of crystallization conditions. Over the course
of the experiment, information flowed in both directions in an iter-
ative fashion to inform decisions about the protein purification
strategy and crystallization conditions.
Solubility enhancements
During the purification optimizations, GlnN, displayed a pro-
pensity to precipitate out of solution as previously noted by van
Rooyen et al. [3]. Fibrous aggregates of GlnN, identified by SDS–
PAGE, routinely appeared upon concentration by ultra-filtration
and in even more dilute fractions such as the elutions from ANX
AF, and SEC. In addition to these ‘‘spontaneous” precipitation
events, information about the limited solubility of GlnN under
more specific conditions emerged from the PEG fractionation steps
and the numerous crystallization trials (see below). These results














Fig. 1. Removal of the primary protein contaminant, a putative GroEL complex, during th
gels (1–3: 7.5% and 4: 10%) comparing alternate strategies for the separation of GlnN fro
lanes labelled S contain molecular weight markers. (b) Electron micrograph of negatively
linked to the corresponding bands in (a) by black arrows. (c) Close association of GroEL anate molecular weight polymers such as PEG and at pH values below
5. At the same time, a systematic investigation of the solubility
limiting effects of various ionic species in the extraction solutions
revealed that, as in the case of GSI [29], GlnN, was particularly sen-
sitive to precipitation by divalent cations. This behaviour could be
prevented in the presence of moderate salt concentrations, such as
found in the crystallization conditions (0.2 M ammonium sul-
phate), and pH values above 4.6 but below 5.8. This partially
reversibility was, therefore, exploited to rapidly purify the GlnN
enzyme as inspired by the previously reported scheme for isolating
GSI using Zn2+ precipitation [29]. The method presented here, how-
ever, differs in several regards: (1) only the Zn2+ fractionation was
used; (2) precipitation took place at pH 7 and not under acidic con-
ditions; (3) the wash solution contained only 2 mM Mg2+ instead of
50 mM; and (4) the resuspension volumes and the salt concentra-
tions were optimized for the recovery of GlnN from the Zn2+ pellet.
During the latter optimizations it was also found that high salt con-
centrations condensed the remaining insoluble fraction, thus, facil-
itating the recovery of soluble GlnN.
Although the sensitivity to precipitation by divalent cations
proved useful for the isolation of pure GlnN (see below), the phe-
nomenon did not explain the spontaneous losses seen in dilute
solutions of the semi-pure protein or the losses observed in the ab-
sence of such ions (data not shown). Solubility enhancing additives
were, therefore, sought in order ameliorate the losses encountered
during the purifications and to overcome the presumed barrier to
crystallization caused by the limited solubility of GlnN. Of these,
glycerol was found to have the greatest effect on GlnN solubility.
The first indication of this came from crystallization trials setup
in the presence of 10% glycerol in an attempt to reduce nucleation
of micro-crystals (see below). At this concentration, glycerol pre-













e development of the purification procedure. (a) Coomassie blue-stained SDS–PAGE
m GroEL: 1 – ANX FF Sepharose, 2 – HIC, ANX-AGB-SEC, and 4 – Zn2+ppt-AGB. The
stained fractions from ANX IEX. The GlnN and GroEL complexes are identified and
d GlnN complexes in the ANX-AGB-SEC fractions as seen with electron microscopy.
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and crystallization solutions. The cryo-protective abilities of glyc-
erol also permitted the long-term storage of the final GlnN crystal-
lization stocks in liquid nitrogen.S 1 2 3 4 S(kDa)
130Removal of large protein contaminants
The second major problem thought to be hindering the crystal-
lization of GlnN was the inability of the early purification proce-
dures to separate GlnN from a similarly sized contaminating
protein complex. This complex, which co-eluted with GlnN from
a number of chromatographic matrices (Fig. 1a), was putatively
identified as GroEL on the basis of its SDS-derived molecular
weight and characteristic geometry, as seen with electron micros-
copy (EM) (Fig. 1b). The EM analyses also revealed a close associa-
tion between the GlnN and GroEL complexes purified by the
sequential ANX-AGB-SEC method (Fig. 1c). GS-GroEL associations
have been noted before [30,31] and could be the reason for their
co-elution from the various chromatographic matrices. The pres-
ence of this contaminant, even at trace levels, was particular con-
cerning because the reported crystallization conditions for the
native protein from E. coli [32] were very similar to the conditions
that produced the majority of crystallization phenomena (see be-
low). The two most successful methods for removing GroEL were
the already proven AGB AF [30] and HIC [32] separations
(Fig. 1a). The latter scheme together with a SEC purification step
proved quite successful, however, the large losses observed during
the three concentration steps precluded its usefulness for prepar-
ing the large quantities of protein needed for crystallization trials.
The AGB affinity step was, therefore, combined with the Zn2+ pre-
cipitation method to produce the final purification protocol (see





Fig. 2. Summary of the novel two-step purification of GlnN from E. coli YMC11.
Samples from each purification step are shown on a silver-stained SDS–PAGE gel
(10%): 1 – CFE (0.67 lg), 2 – resolubilized ZnCl2 precipitate (0.33 lg), 3 – AGB eluent
(0.07 lg), and 4 – ultrafiltration retentate (0.07 lg). Lanes labelled S contained
molecular weights markers and the position of the GlnN monomer is shown by an
arrow. The colour image of the silver-stained gel was split into RGB channels and
the grey levels of the blue channel were adjusted for presentation purposes but no
bands in the gel image were masked by this alteration.Final purification protocol
Several additional enhancements were made to the purity and
stability of the GlnN preparation protocols. Firstly, the purity of
the fraction eluted from the Affi-Gel Blue affinity matrix was im-
proved by changing from an ionic based elution to a more specific
competitive elution with ATP. This alteration also facilitated the
next improvement which was the inhibition of GlnN by the well
known GS inhibitor MetSox, the aim of which was the improved
stability of the final preparation. The purity of the affinity fraction
was also sufficiently high that the additional selectivity of the
100 kDa MWCO filter was unnecessary. A 10-kDa MWCO filter
was used instead, thus, allowing increased centrifugal speeds
and, therefore, faster isolations of higher concentrations of protein
(6–8 mg/ml) for storage and crystallization.
A summary of the final purification scheme is given in Table 1
and representative samples taken during the purification process
are shown in Fig. 2. It can be seen from these results that pure GlnN
was isolated quickly and easily with this method. The Zn2+ precip-Table 1
Purification statistics for production of recombinant GlnN from E. coli YMC11.
Purification step Volume (ml) Total protein (mg) Total enzyme acti
Clarified cell lysate 44 241 129
Solubilized Zn2+ precipitate 50 38.7 29.2
AGB affinity eluent 9 1.59 17.5
Ultra-filtration retentated 0.105 0.65 n/a
Values in the table represent the average of at least two measurements and all assays w
a Activity is expressed as lmoles of glutamyl hydroxamate formed per min.
b Purity was calculated from densitometry of bands in Coomassie-stained 10% SDS–P
c Purification fold = specific activity/specific activity of clarified cell lysate.
d The pooled AGB ATP eluent was treated with MetSox before incubation for 16 h at 4itation step alone was able to produce 63% pure GlnN at concentra-
tions as high as 6 mg/ml (as measured by densitometry of all
protein bands above 25 kDa). The subsequent affinity purification
step removed all traces of contaminants and resulted in a 22-fold
total enrichment of the GlnN above level found in the starting
material. The disagreement between the SDS–PAGE and specific
activity derived purity values, 10 and 1.4-fold, respectively, sug-
gested that the affinity purification step also removes a large frac-
tion of inactive but soluble GlnN material. Together with the
interactions with GroEL noted above, these results suggest that
the spontaneous aggregation of GlnN was caused by the associa-
tion of denatured molecules.
Unfortunately, this high purity came at the cost of a poor yield,
with losses occurring primarily at the Zn2+ precipitation (77% loss),
AGB AF (additional 9% loss), and final concentration steps (addi-
tional 8.5% loss). Nonetheless, these losses were tolerable consider-
ing the rapidity, ease, and scalability of the purification method. As
demonstrated here, despite only recovering 5.5% of the total en-
zyme units from a modest 44 ml of CFE, the protocol produced en-
ough pure GlnN enzyme for 300 batch crystallizations (each
requiring 1 ll @ 2 mg/ml).
Crystallization of full-length GlnN
The optimizations to the purification protocol produced several
different preparations with varying purities, stabilities, and solute
compositions. From the outset, attempts were made to crystallize
these preparations and the successes of the optimizations werevity (U)a Specific activity (U/mg) Yield (%) Purityb (%) Purification foldc
0.534 100 6 1
0.754 23 63 1.4
11.0 14 100 20.6
ere carried out at dilutions within their linear response regions.
AGE gels.
C.
Fig. 3. Microscopic investigations of GlnN micro-crystals. (a) Photograph of platelet micro-crystals grown using 10% PEG 4000 and 0.1 M (NH4)2SO4 in tris pH 8.0. (b) Low
magnification transmission electron micrograph of negatively stained micro-crystals grown in 12.5% PEG 3350 and 0.1 M (NH4)2SO4 in bis–tris pH 5.5. (c) Higher
magnification electron micrograph of crystals similar to those in (b). The corresponding power spectrum (bottom left) and a Fourier-filtered/correlation-averaged view of the
crystal lattice (upper right) are shown as insets. Grey levels were adjusted for presentation purposes.
Fig. 4. Growth, identification, and characterization of GlnN crystals. (a) Photograph
of GlnN crystals grown over several days following streak seeding. (b) Silver-stained
SDS–PAGE gel (10%) identifying the crystals (five washed 0.8 lm crystals) as GlnN
(1.9 lg of crystallization stock). Molecular weight markers were loaded into the
lane marked S. (c) Diffraction (3 Å resolution) from a cryo-protected P1 GlnN
crystal. The grey levels in images (a) and (c) were adjusted for presentation
purposes. The colour image of the silver-stained gel in (b) was split into RGB
channels and the blue channel was adjusted for contrast but no bands in the gel
image were masked by this alteration.
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als. The commercial screens yielded a number of promising leadsand for the most part, these were achieved with the PEG 3350/
4000 precipitants and manifested as showers of plate-like micro-
crystals (Fig. 3). The growth of crystals following precipitation,
their small size, and the numerous macro-seedings necessary to
enlarge them all suggested that only a sub-fraction of GlnN mole-
cules were forming the crystals and this was, therefore, a major
barrier to the attainment of large, well-diffracting crystals.
Following the improvements to the purity, solubility and stabil-
ity of the GlnN protein preparations (described above), complete
re-screening using a commercial matrix (Hampton Crystal Screen)
yielded much improved crystallization conditions. As before, the
initial screening results produced a large number of precipitation
phenomena, particularly in the PEG conditions, but subsequent
optimizations of the protein and precipitant concentrations pro-
duced irregular protein crystals after 4 days of growth for a diluted
Hampton condition 20: 0.1 M ammonium sulphate, 50 mM sodium
acetate trihydrate pH 4.6, and 12.5% PEG 4000. After mapping the
meta-stable zone, streak-seeding produced single regular mono-
clinic crystals (Fig. 4a) and these were conclusively identified as
GlnN by SDS–PAGE (Fig. 4b). Crystals diffracting to 3.0 Å in a space
group of P1 (with unit cell dimensions a = 141.79 Å, b = 148.30 Å,
c = 59.32 Å, a = 115.76, b = 93.65, c = 115.99) were routinely
produced following several days of growth (Fig. 4c).Conclusions
The work presented here has addressed the shortcomings of the
currently available methods for the isolation of suitable GlnN sam-
ples for structural characterization. It has been demonstrated that
by exploiting the partially reversible precipitation of GlnN by Zn2+
ions and the selectivity of nucleotide-analogue affinity chromatog-
raphy, it is possible to produce sufficient quantities of highly pure
material for crystallization. The resultant improvements to the
purity, solubility, and stability of the GlnN material achieved with
the new method have also lead to the discovery of the conditions
for the production of diffraction quality crystals of ATP- and MetS-
ox-bound GlnN. The preliminary data collected from these crystals
is promising (3 Å resolution) and will, in future work, be used to
solve the first crystal structure of a type III GS enzymes.Acknowledgments
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